[Federal Register Volume 78, Number 58 (Tuesday, March 26, 2013)]
[Notices]
[Page 18360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-06835]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Prospective Grant of Start-Up Exclusive License: Manual Device
for Constructing Tissue Micro Arrays and Methods for Making Cryo Arrays
for Use in Association With the Device
AGENCY: National Institutes of Health, Public Health Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH),
Department of Health and Human Services, is contemplating the grant of
a start-up exclusive license to practice the inventions embodied in
U.S. Patent No. 7,854,899, (E-098-2004/0) filed 08/26/2004 and issued
12/20/2010 entitled ``Template Methods and Device for Preparing Sample
Arrays''; by Hewitt et al. (NCI); and U.S. Patent No. 6,951,761 9 (E-
064-2001/0) filed 08/30/2002 and issued 11/04/2005 ``Measurements of
Multiple Molecules Using a Cryoarray'' by Star et al. (NIDDK) to
Micatu, Inc. having a place of business at 231 West Water Street,
Elmira, NY 14901. The patent rights in this invention have been
assigned to the United States of America.
DATES: Only written comments and/or application for a license that are
received by the NIH Office of Technology Transfer on or before April
10, 2013 will be considered.
ADDRESSES: Requests for a copy of the patent application, inquiries,
comments and other materials relating to the contemplated license
should be directed to: Tedd Fenn, Office of Technology Transfer,
National Institutes of Health, 6011 Executive Boulevard, Suite 325,
Rockville, MD 20852-3804; Email: [email protected]; Telephone: 301-
435-5031; Facsimile: 301-402-0220.
SUPPLEMENTARY INFORMATION: The prospective worldwide exclusive license
will be royalty bearing and will comply with the terms and conditions
of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license
may be granted unless, within fifteen (15) days from the date of this
published Notice, NIH receives written evidence and argument that
establishes that the grant of the license would not be consistent with
the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
The patents relate to a device for tissue microarray construction
having a block of embedding medium, a platform configured to retain the
block, a templates secured to the platform and aligned to guide needles
into the embedding block; and methods of making a block containing
liquid biological samples that can be frozen and sectioned to make
tissue microarray.
The field of use may be limited to the field of devices for
construction of tissue microarrays.
Properly filed competing applications for a license filed in
response to this notice will be treated as objections to the
contemplated license. Comments and objections submitted in response to
this notice will not be made available for public inspection, and, to
the extent permitted by law, will not be released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: March 18, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development & Transfer, Office of
Technology Transfer, National Institutes of Health.
[FR Doc. 2013-06835 Filed 3-25-13; 8:45 am]
BILLING CODE 4140-01-P